Argenx uses cookies on this site to enhance your user experience. More information

I agree
  • Events
  • Contact
  • Home
  • About us
  • Products
  • Partnering
  • Investors
  • News & Events
  • Events
  • Contact
  • Home
  • About us
    • Overview
    • Strategy
    • Management team
    • Board of Directors
    • Careers
  • Products
    • Overview
    • Autoimmunity
      • Efgartigimod
    • Oncology
      • ARGX-110
      • ARGX-111
      • ARGX-115
    • Discovery programs
    • Technology
  • Partnering
    • Opportunities
    • Partnerships
    • Innovative Access Program
  • Investors
    • Stock information
    • Events & Presentations
    • Financial Information
      • Annual reports
      • Results center
      • SEC filings
    • Financial calendar
    • Shareholder Meeting
    • Analyst coverage
    • Corporate Governance
      • Committee Composition
    • Contact us
  • News & Events
    • Press releases
    • Events & Presentations
    • Downloads
  • Home
  • Sitemap
  • Home
  • About us
    • Overview
    • Strategy
    • Management team
    • Board of Directors
    • Careers
  • Products
    • Overview
    • Autoimmunity
      • Efgartigimod
    • Oncology
      • ARGX-110
      • ARGX-111
      • ARGX-115
    • Discovery programs
    • Technology
      • SIMPLE Antibody™
      • NHance™
      • ABDEG™
      • Potelligent®
  • Partnering
    • Opportunities
    • Partnerships
    • Innovative Access Program
  • Investors
    • Stock information
    • Events & Presentations
    • Financial Information
      • Annual reports
      • Results center
      • SEC filings
    • Financial calendar
    • Shareholder Meeting
    • Analyst coverage
    • Corporate Governance
      • Committee Composition
    • Contact us
  • News & Events
    • Press releases
    • Events & Presentations
    • Downloads

  • Events
  • Contact

  • Disclaimer
  • Cookie policy
  • Sitemap

  • Board
Contact

argenx SE
Breda, The Netherlands
T +31 763 030 488

info@argenx.com

 

argenx BVBA
Zwijnaarde, Belgium
T +32 9 310 34 00

Downloads
argenx Annual Report 2017 Cowen presentation, March 2018 Y2017 Financial results and Q4 Business update
Follow us

2018 © argenx

| Disclaimer | Cookie policy | Sitemap
  • Home
  • About us
  • Products
  • Partnering
  • Investors
  • News & Events
Created by Cantilis